Sale!

Methylmalonic Acid Quantitative Serum Tes Cost

Original price was: 520 د.إ.Current price is: 470 د.إ.

-10%

The Methylmalonic Acid Quantitative Serum Test is a diagnostic tool used to measure the levels of methylmalonic acid in the blood. Elevated levels of this substance can be an indicator of Vitamin B12 deficiency or certain metabolic disorders such as methylmalonic acidemia. The test involves collecting a blood sample from the patient, which is then analyzed in a laboratory setting to determine the concentration of methylmalonic acid present in the serum.

At DNA Labs UAE, this test is offered for a cost of 470 AED. DNA Labs UAE is known for its state-of-the-art facilities and the use of advanced technologies in conducting a wide range of medical and genetic tests. The Methylmalonic Acid Quantitative Serum Test at DNA Labs UAE provides accurate and reliable results, aiding healthcare providers in diagnosing and managing conditions associated with abnormal methylmalonic acid levels effectively.

Description

METHYLMALONIC ACID QUANTITATIVE SERUM Test

Test Name: METHYLMALONIC ACID QUANTITATIVE SERUM Test

Components: Price: 470.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Separate serum within 1 hour of collection. Ship refrigerated or frozen.

Report Delivery: SampleFri by 6 pm; Report Sat

Method: LC-MS/MS

Test type: Nutritional disorders

Doctor: Physician

Test Department: GENETIC

Pre Test Information: No special preparation required

Test Details:

The Methylmalonic Acid (MMA) Quantitative Serum Test is a blood test that measures the level of methylmalonic acid in the blood. Methylmalonic acid is a substance that is produced during the breakdown of certain proteins and fats in the body. This test is primarily used to diagnose and monitor vitamin B12 deficiency and certain types of metabolic disorders.

Vitamin B12 is essential for the proper functioning of the nervous system and the production of red blood cells. Deficiency in vitamin B12 can lead to an increase in methylmalonic acid levels in the blood. The test is usually ordered if a person has symptoms of vitamin B12 deficiency, such as fatigue, weakness, numbness or tingling in the hands and feet, difficulty walking, or memory problems. It may also be ordered if a person has a known vitamin B12 deficiency or a condition that affects the absorption of vitamin B12, such as pernicious anemia or gastrointestinal disorders.

During the test, a healthcare provider will collect a blood sample from a vein in the arm. The sample is then sent to a laboratory for analysis. The results of the test will indicate the level of methylmalonic acid in the blood. Elevated levels of methylmalonic acid suggest a vitamin B12 deficiency or a metabolic disorder.

It is important to note that the MMA Quantitative Serum Test is just one part of the diagnostic process for vitamin B12 deficiency and metabolic disorders. Additional tests, such as a complete blood count (CBC) and a vitamin B12 level test, may be necessary to confirm a diagnosis.

If a person is diagnosed with a vitamin B12 deficiency, treatment may involve vitamin B12 supplements or injections to restore normal levels. For metabolic disorders, treatment options will depend on the specific condition and may involve dietary changes, medications, or other interventions.

Overall, the MMA Quantitative Serum Test is a useful tool in diagnosing and monitoring vitamin B12 deficiency and certain metabolic disorders. It provides valuable information that can help healthcare providers determine the most appropriate treatment plan for their patients.

Test Name	METHYLMALONIC ACID QUANTITATIVE SERUM Test
Components
Price	470.0 AED
Sample Condition	2 mL (1 mL min.) serum from 1 SST. Separate serum within 1 hour of collection. Ship refrigerated or frozen.
Report Delivery	SampleFri by 6 pm; Report Sat
Method	LC-MS/MS
Test type	Nutritional disorders
Doctor	Physician
Test Department:	GENETIC
Pre Test Information	No special preparation required
Test Details	The Methylmalonic Acid (MMA) Quantitative Serum Test is a blood test that measures the level of methylmalonic acid in the blood. Methylmalonic acid is a substance that is produced during the breakdown of certain proteins and fats in the body. This test is primarily used to diagnose and monitor vitamin B12 deficiency and certain types of metabolic disorders. Vitamin B12 is essential for the proper functioning of the nervous system and the production of red blood cells. Deficiency in vitamin B12 can lead to an increase in methylmalonic acid levels in the blood. The test is usually ordered if a person has symptoms of vitamin B12 deficiency, such as fatigue, weakness, numbness or tingling in the hands and feet, difficulty walking, or memory problems. It may also be ordered if a person has a known vitamin B12 deficiency or a condition that affects the absorption of vitamin B12, such as pernicious anemia or gastrointestinal disorders. During the test, a healthcare provider will collect a blood sample from a vein in the arm. The sample is then sent to a laboratory for analysis. The results of the test will indicate the level of methylmalonic acid in the blood. Elevated levels of methylmalonic acid suggest a vitamin B12 deficiency or a metabolic disorder. It is important to note that the MMA Quantitative Serum Test is just one part of the diagnostic process for vitamin B12 deficiency and metabolic disorders. Additional tests, such as a complete blood count (CBC) and a vitamin B12 level test, may be necessary to confirm a diagnosis. If a person is diagnosed with a vitamin B12 deficiency, treatment may involve vitamin B12 supplements or injections to restore normal levels. For metabolic disorders, treatment options will depend on the specific condition and may involve dietary changes, medications, or other interventions. Overall, the MMA Quantitative Serum Test is a useful tool in diagnosing and monitoring vitamin B12 deficiency and certain metabolic disorders. It provides valuable information that can help healthcare providers determine the most appropriate treatment plan for their patients.